Seroepidemiology of hepatitis A in the Croatian population

Hepatitis Monthly

Volumn 11, Issue 12, 2011, Pages 997-999

  Vilibic Cavlek, Tatjana ^a   Kucinar, Jasmina ^b   Ljubin Sternak, Suncanica ^a   Kolaric, Branko ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Istria County Institute of Public Health   (Croatia)

^c UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Croatia; Epidemiology; Hepatitis A virus; Seroepidemiologic studies

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; ARTICLE; CHILD; CONTROLLED STUDY; CROATIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS A; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RATE; INFECTION RISK; INFECTION SENSITIVITY; MALE; POPULATION RISK; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; URBAN RURAL DIFFERENCE;

EID: 84855817965     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/kowsar.1735143X.4150     Document Type: Article

References (20)

1. World Health organization. Hepatitis A vaccines: WHo position paper. Wkly Epidemiol Rec. 2000;75:38-44.
2. Hollinger FB, Emerson SU. Hepatitis A virus. In: Knipe DM Hp, Griffin DE, et al, editor. Fields Virology. philadelphia: Lippincott Williams & Wilkins publishers; 2001. p. 799-840.
3. Melnick JL. History and epidemiology of hepatitis A virus. J Infect Dis. 1995;171(Suppl 1):S2-8.
4. Tsega E, Nordenfelt E, Mengesha B, Hansson BG, Tsega M, Lindberg J. Age-specific prevalence of hepatitis A virus antibody in ethiopian children. Scand J Infect Dis. 1990;22(2):145-8.
5. Ansaldi F, Bruzzone B, Rota MC, Bella A, Ciofi degli Atti M, Durando P, et al. Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study. Eur J Epidemiol. 2008;23(1):45-53.
6. Baaten GG, Sonder GJ, Dukers NH, Coutinho RA, Van den Hoek JA. Population-based study on the seroprevalence of hepatitis A, B, and C virus infection in Amsterdam, 2004. J Med Virol. 2007;79(12):1802-10.
7. Chlibek R, Cecetkova B, Smetana J, Prymula R, Kohl I. Serop-revalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age. Epidemiol Mikrobiol Imunol. 2006;55(3):99-104.
8. Dominguez A, Bruguera M, Plans P, Espunes J, Costa J, Plasencia A, et al. Declining hepatitis A seroprevalence in adults in Catalonia (Spain): a population-based study. BMC Infect Dis. 2007;7:73.
9. Moisseeva AV, Marichev IL, Biloschitchkay NA, Pavlenko KI, Novik LV, Kovinko LV, et al. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine. J Viral Hepat. 2008;15(Suppl 2):43-6.
10. Mossong J, Putz L, Patiny S, Schneider F. Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg. Epidemiol Infect. 2006;134(4):808-13.
11. Quaglio G, Ramadani N, pattaro C, Cami A, Dentico P, Volpe A, et al. prevalence and risk factors for viral hepatitis in the Kosovarian population: implications for health policy. J Med Virol. 2008;80(5):833-40.
12. Vatev NT, Atanasova MV, Stoilova YD, Chervenyakova TP, Troyancheva MG. Seroprevalence of hepatitis A viral infection in Plovdiv, Bulgaria. Folia Med (Plovdiv). 2009;51(1):70-3.
13. Bozicevic I, Rode OD, Lepej SZ, Johnston LG, Stulhofer A, Dominkovic Z, et al. prevalence of sexually transmitted infections among men who have sex with men in Zagreb, Croatia. AIDS Behav. 2009;13(2):303-9.
14. puntari D, Vodopija I, Baklaic Z, Ljubicic M. Immunity against hepatitis A in younger age groups and the basis for an immunization program. Lijecnicki vjesnik. 1995;117(7-8):167.
15. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. prevalence of markers for hepatitis A, B and C in the German population. Results of the German national Health Interview and examination Survey 1998. Eur J Epidemiol. 2001;17(5):429-35.
16. Morris MC, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiol Infect. 2002;128(3):457-63.
17. Cilla G, Perez-Trallero E, Artieda J, Serrano-Bengoechea E, Montes M, Vicente D. Marked decrease in the incidence and prevalence of hepatitis A in the Basque Country, Spain, 1986-2004. Epidemiol Infect. 2007;135(3):402-8.
18. Saberifiroozi M. prevention of hepatitis A infection. Hepat Mon. 2005;5(1):19-27.
19. Ghorbani GA, Alavian SM, Assari S. Seroepidemiology of Hepatitis A Virus in Iranian Soldiers in 2006: Do They need Vaccination? Hepat Mon. 2007;7(1):7-9.
20. Luksamijarulkul P, Sujirarat D, Charupoonphol P. Risk behaviors, occupational risk and seroprevalence of hepatitis B and A infections among public cleansing workers of Bangkok Metropolis. Hepat Mon. 2008;8(1):35-40.